Impact Factor 4.848 | CiteScore 3.5
More on impact ›

CORRECTION article

Front. Oncol., 23 April 2021 | https://doi.org/10.3389/fonc.2021.679526

Corrigendum: Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach

  • 1Pediatric Critical Care Medicine, University of Texas at MD Anderson Cancer Center, Houston, TX, United States
  • 2Pediatric Stem Cell Transplantation and Cellular Therapy and CARTOX Program, University of Texas at MD Anderson Cancer Center, Houston, TX, United States

In the original article, there was a mistake in Table 2. Possible Screening for pMODS for Pediatric and Adolescent-Young Adult (AYA) HCT Patients as published.

TABLE 2
www.frontiersin.org

Table 2 Possible Screening for pMODS for Pediatric and Adolescent-Young Adult (AYA) HCT Patientsab.

The following in Table 2 has been corrected:

Respiratory: Score 0 and Score 2; CV: Score 2; Renal: Score 4; Hematologic: Score 0, Score 1, Score 2, and Score 3; CNS: Score 0 and Score 4; Immune Reconstitution: Score 1 and Score 2 and Footnote f.

The corrected Table 2. Possible Screening for pMODS for Pediatric and Adolescent-Young Adult (AYA) HCT Patients appears below.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Reference

75. Rowlings PA, Przepiorka D, Klein JP, Gale RP, Passweg JR, Henslee-Downey PJ, et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol (1997) 97(4):855–64. doi: 10.1046/j.1365-2141.1997.1112925.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: pediatric stem cell transplantation, pediatric critical care, multiple organ dysfunction, pediatric critical care illness severity scores, pediatric multi-organ dysfunction syndrome

Citation: Ahmad AH and Mahadeo KM (2021) Corrigendum: Perspective: A Framework to Screen Pediatric and Adolescent Hematopoietic Cellular Therapy Patients for Organ Dysfunction: Time for a Multi-Disciplinary and Longitudinal Approach. Front. Oncol. 11:679526. doi: 10.3389/fonc.2021.679526

Received: 12 March 2021; Accepted: 12 March 2021;
Published: 23 April 2021.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Ahmad and Mahadeo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Kris M. Mahadeo, kmmahadeo@mdanderson.org